Aigen Investment Management, LP Rx Sight, Inc. Transaction History

Aigen Investment Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$50.42 - $64.29 $250,184 - $319,006	-4,962 Reduced 56.5%	3,820 $229,000
Q1 2024 May 14, 2024	SELL	$35.51 - $57.92 $17,009 - $27,743	-479 Reduced 5.17%	8,782 $452,000
Q4 2023 Feb 09, 2024	SELL	$20.91 - $40.9 $226,601 - $443,233	-10,837 Reduced 53.92%	9,261 $373,000
Q3 2023 Nov 13, 2023	BUY	$27.05 - $33.37 $543,650 - $670,670	20,098 New	20,098 $560,000

225

32.3M

394K

32K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.25B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.